BD, Suttons Creek partner to streamline combination product development
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
Q2 2026 analysis shows expanding approvals, stronger uptake, and a shift toward evidence-driven biosimilar evaluation
The approval was driven by data from the Phase III TULIP-SC trial
His appointment is expected to strengthen scientific input in policy discussions across public health, biotech, and translational research
New model focuses on continuity of care, combining therapy, routine and social engagement to support long-term recovery
New plan integrates critical illness protection, market-linked health fund and preventive care platform for holistic financial and health security
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance
Subscribe To Our Newsletter & Stay Updated